Centrum Medyczne Damiana Holding Sp. z o.o.
- Address
- lock Available on a paid plan
Centrum Medyczne Damiana Holding Sp. z o.o. - Migraine Research Center
Centrum Medyczne Damiana Holding Sp. z o.o. is a specialized clinical research facility focused on advancing therapeutic options for patients suffering from neurological conditions, with particular expertise in migraine management. The center conducts comprehensive Phase 4 clinical trials investigating both acute and preventive treatment strategies for migraine headaches, serving patients who face challenges with conventional therapies.
- Acute migraine treatment research for patients unsuitable for triptan therapy
- Preventive migraine management studies for patients with inadequate response to oral preventive medications
- Evaluation of novel CGRP receptor antagonists like rimegepant in diverse patient populations
The research center specializes in evaluating rimegepant efficacy and tolerability through randomized, double-blind, placebo-controlled trials. Their clinical programs address critical unmet needs for patients with migraine attacks with or without aura, including those who have failed multiple categories of conventional preventive medications. The center's expertise encompasses both acute treatment protocols measuring pain relief outcomes and prophylactic regimens using every-other-day (EOD) dosing strategies to reduce monthly migraine frequency.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Damiana Holding Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Investigation of RO7507062 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Systemic Lupus Erythematosus Patients | F. Hoffmann-La Roche AG | Phase I | Not Recruiting | Oct 2023 | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.